Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Head Neck ; 41(2): E21-E25, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30552825

RESUMO

BACKGROUND: Kaposi's sarcoma (KS) is the most prevalent malignant neoplasia in human immunodeficiency virus positive (HIV+) patients for which the primary mode of management was chemotherapy. METHODS: We have presented the case of a newly diagnosed HIV+ male patient who was diagnosed with a pedunculated nodule in the anterior region of the hard palate, measuring 3.5 cm in diameter and with 2 months of evolution. RESULTS: Histopathological examination confirmed the clinical hypothesis of KS. Soon after the diagnosis, the patient started using combined antiretroviral therapy (Biovir and Kaletra), presenting a significant reduction of the lesion after 4 weeks. With 1.5 cm in diameter, the lesion was surgically removed. The patient was followed-up for 10 years without any recurrence. CONCLUSION: In antiretroviral-naive patients with a well-preserved immune system, the use of cART may be efficient in reducing the progression of the KS lesions, thus avoiding the use of chemotherapeutic agents.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Infecções por HIV/complicações , Lamivudina/uso terapêutico , Lopinavir/uso terapêutico , Neoplasias Bucais/tratamento farmacológico , Ritonavir/uso terapêutico , Sarcoma de Kaposi/tratamento farmacológico , Zidovudina/uso terapêutico , Terapia Antirretroviral de Alta Atividade , Combinação de Medicamentos , Infecções por HIV/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Bucais/patologia , Neoplasias Bucais/virologia , Sarcoma de Kaposi/patologia , Sarcoma de Kaposi/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA